Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1824 of 6351
-
Which Pre-Transplant chemo works best for MDS/AML? new trial aims to find out
Disease control Stopped earlyThis phase II trials studies the effect of treosulfan-based versus clofarabine-based conditioning regimens before donor hematopoietic stem cell transplant in treating patients with myelodysplastic syndromes or acute myeloid leukemia. Chemotherapy drugs, such as treosulfan, fludar…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Coffee made from wormwood plant tested against prostate cancer return
Disease control CompletedUntil now, clinicians have been challenged to improve the treatment of biochemically recurrent (BCR) prostate cancer in which prostatic specific antigen (PSA) rises without radiological or clinical progression years after localized treatment (radical prostatectomy or radiation th…
Phase 2 • Sponsor: Zin W Myint • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can we map CMV's spread in daycares to shield future pregnancies?
Knowledge-focused CancelledThe goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one…
Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New drug combo aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of the study is to evaluate safety and tolerability of the combination of cevostamab plus elranatamab and also determine the recommended Phase II regimen (RP2R) for the study treatment. The study consists of a safety lead-in stage, and an expansion stage.
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new workout boost balance in teens with movement disabilities?
Symptom relief CompletedThe purpose of this research study is to test the feasibility and response of a new exercise protocol on improving physical activity in adolescents with cerebral palsy.
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of ZEN003694 when given together with abemaciclib in treating patients with NUT carcinoma, breast cancer or other solid tumors that have spread from where it first started (primary site) to other places in the body …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for tough prostate cancer: first human trial of VIR-5500 begins
Disease control Recruiting nowThe study will be conducted in 4 parts and will commence with dose escalation of VIR-5500 as a monotherapy (Part 1), followed by combination escalation (Part 3a), monotherapy dose expansion (Part 2) and combination dose expansion (Part 4a). * Part 1 (Monotherapy Dose Escalation)…
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New drug shows promise for slowing liver damage in rare genetic disease
Disease control OngoingThe main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein. People who have taken part in previous fazirsiran studies (AROAAT2001 \[NCT03945292\] or AROAAT2002 \[NCT03…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Radioactive microspheres show promise in early liver cancer trial
Disease control CompletedThe goal of this clinical trial is to evaluate the safety and efficacy of NRT6003 Injection in patients with unresectable HCC.
Phase 1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Spinal cord injury drug trial halted early
Disease control CompletedA Randomized, Double-Blind, Placebo-Controlled Phase 1b/2a Study of NVG-291 in Spinal Cord Injury Subjects
Phase 1/2 • Sponsor: NervGen Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New lifestyle program aims to tame type 2 diabetes with less medication
Disease control Recruiting nowA Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + Glycemic Excursion Minimization (RC+GEM); a program that provides RC in addition to continuous glucose monitors (CGM) within a structured, se…
Sponsor: Chiara Fabris, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Smart bands vs. paper guides: which builds better senior fitness?
Prevention Recruiting nowSubjects are divided into two groups, (1) Control (Ctrl) and (2) Smart Exercise (SE) group. Participants in the Ctrl group are instructed to perform resistance band training twice weekly according to a paper-based exercise guide, whereas participants in the SE group are instructe…
Sponsor: National Cheng-Kung University Hospital • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
New hope for PBC: experimental drug CS0159 enters Mid-Stage trial
Disease control OngoingA phase II study to evaluate safety, tolerability and efficacy of CS0159 in patients with PBC (Primary Biliary Cholangitis).
Phase 2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
High-Tech cycling could help seniors stay steady on their feet
Prevention Recruiting nowSubjects are divided into two groups, (1) Control (Ctrl) and (2) Smart Exercise (SE) group. Participants in the Ctrl group are instructed to perform combined muscle strength and coordination exercises twice weekly, with each session lasting 30 minutes, following an exercise guide…
Sponsor: National Cheng-Kung University Hospital • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Short therapy shows promise for Kids' nightmares and suicide risk
Symptom relief CompletedThe goal of this clinical trial is to assess the efficacy of CBT-NC intervention to determine its impact on mental health and suicidality in children ages 6-17. The main aims are: Aim 1: Examine CBT-NC efficacy for improving nightmare distress and frequency in youth with chronic…
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Simple antibiotic pill may protect mothers and babies during induced labor
Disease control Recruiting nowThis is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.
Phase 1 • Sponsor: Arrowhead Regional Medical Center • Aim: Disease control
Last updated Jun 26, 2026 16:13 UTC
-
AI tool aims to end guesswork in depression treatment
Knowledge-focused OngoingOPADE is a non-profit, observational, multicenter, open-label study aimed at defining personalized treatment for Major Depressive Disorder (MDD). In particular, we will combine genetics, epigenetics, microbiome, immune response data together with anamnesis, questionnaires, electr…
Sponsor: Alessio Fasano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Smart supplement strategy could save babies in ethiopia
Prevention CompletedThe goal of this randomized effectiveness study is to evaluate the different targeting strategies for the delivery of balanced energy and protein (BEP) supplements among pregnant women in Addis Ababa, Ethiopia. The main goals of the study are to: 1) determine the effectiveness of…
Sponsor: Harvard School of Public Health (HSPH) • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
New Short-Course malaria treatment could prevent relapses
Disease control CompletedSignificant gains have been made in reducing the overall burden of malaria worldwide, however these have been far greater for Plasmodium falciparum than P. vivax. P. vivax remains a major obstacle to malaria control and elimination efforts, largely due to its ability to form dor…
Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can better healthcare access save hearts after prison?
Knowledge-focused OngoingPeople released from prison experience two times higher cardiovascular (CV) mortality than the general population, have a high prevalence of poor CV health and increased risk of CV events within 2 years of release. Access to high quality healthcare following release from prison i…
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC